lithium has been researched along with Parkinson Disease, Secondary in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 19 (86.36) | 18.7374 |
1990's | 2 (9.09) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (4.55) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhattacharjee, S; Chadwick, G; Yela, R | 1 |
Degkwitz, R | 1 |
Bánki, CM; Perényi, A; Rihmer, Z | 1 |
Barreira, P; Lipinski, JF; Zubenko, GS | 1 |
Lavy, S; Reches, A; Tietler, J | 1 |
Annable, L; Bélanger, MC; Chouinard, G; Ghadirian, AM | 1 |
Byerly, MJ; Christensen, RC; Evans, OL | 1 |
Gabriel, E; Karobath, M; Lenz, G | 1 |
Klawans, HL; Kramer, J | 1 |
Cottereau, MJ; Deniker, P; Diepart, E | 1 |
Merskey, H | 1 |
Lutz, EG | 1 |
Bathien, N; Rondot, P | 1 |
Branchey, MH; Simpson, GM | 1 |
Johnels, B; Wålinder, J; Wallin, L | 1 |
Davis, HK | 1 |
Sansone, ME; Ziegler, DK | 1 |
Chouinard, G | 1 |
Jankovic, J; Orman, J | 1 |
Valdiserri, EV | 1 |
Bertagna, L | 1 |
Aimard, G; Chazot, G; Devic, M; Eyssette, M; Fournis, Y | 1 |
3 review(s) available for lithium and Parkinson Disease, Secondary
Article | Year |
---|---|
[Tardive dyskinesia induced by neuroleptics. A review of the literature].
Topics: Adolescent; Adult; Age Factors; Aged; Antipsychotic Agents; Athetosis; Baclofen; Child; Chorea; Diagnosis, Differential; Drug Hypersensitivity; Dyskinesia, Drug-Induced; Female; Humans; Lithium; Male; Middle Aged; Oral Manifestations; Parkinson Disease, Secondary; Sex Factors; Substance Withdrawal Syndrome | 1979 |
Neurology and psychopharmacology.
Topics: Analgesia; Depression; Humans; Huntington Disease; Hysteria; Lithium; Movement Disorders; Parkinson Disease; Parkinson Disease, Secondary; Phenothiazines; Psychopharmacology; Psychotic Disorders; Psychotropic Drugs; Schizophrenia; Thioxanthenes | 1975 |
Lithium toxicity: a review of neurologic complications.
Topics: Antipsychotic Agents; Drug Interactions; Electroencephalography; Encephalitis; Humans; Lithium; Neuromuscular Junction; Parkinson Disease, Secondary; Renal Dialysis | 1985 |
2 trial(s) available for lithium and Parkinson Disease, Secondary
Article | Year |
---|---|
The use of benzodiazepines in the treatment of manic-depressive illness.
Topics: Acute Disease; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Carbamazepine; Clinical Trials as Topic; Clonazepam; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Haloperidol; Humans; Lithium; Lorazepam; Parkinson Disease, Secondary; Random Allocation; Schizophrenia | 1988 |
Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias.
Topics: Chorea; Clinical Trials as Topic; Drug Synergism; Dystonia; Humans; Lithium; Middle Aged; Movement Disorders; Nervous System Diseases; Parkinson Disease, Secondary; Tetrabenazine; Tic Disorders | 1988 |
17 other study(ies) available for lithium and Parkinson Disease, Secondary
Article | Year |
---|---|
Can lithium unmask the preclinical Parkinsonian features?
Topics: Aged; Antipsychotic Agents; Biomarkers; Bipolar Disorder; Corpus Striatum; Diagnosis, Differential; Dopamine; Humans; Lithium; Male; Parkinson Disease; Parkinson Disease, Secondary; Putamen; Radiography | 2013 |
[Psychotropic drugs. Sense and nonsense in the prescription of sedating, psycholeptic and hypnotic drugs].
Topics: Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Depression; Humans; Hypnotics and Sedatives; Lithium; Parkinson Disease, Secondary; Psychotropic Drugs | 1980 |
Parkinsonian symptoms with lithium, lithium-neuroleptic, and lithium-antidepressant treatment.
Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Bipolar Disorder; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Lithium; Middle Aged; Parkinson Disease, Secondary; Psychotic Disorders | 1983 |
Development of tolerance to the therapeutic effect of amantadine on akathisia.
Topics: Adult; Akathisia, Drug-Induced; Amantadine; Bipolar Disorder; Drug Tolerance; Female; Haloperidol; Humans; Lithium; Male; Middle Aged; Parkinson Disease, Secondary; Psychomotor Agitation | 1984 |
Parkinsonism due to lithium carbonate poisoning.
Topics: Humans; Lithium; Lithium Carbonate; Male; Middle Aged; Parkinson Disease, Secondary | 1981 |
A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients.
Topics: Adult; Aged; Ambulatory Care; Antipsychotic Agents; Bipolar Disorder; Cross-Sectional Studies; Depressive Disorder; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Lithium; Male; Middle Aged; Mood Disorders; Parkinson Disease, Secondary; Prevalence; Psychiatric Status Rating Scales; Regression Analysis; Treatment Outcome | 1996 |
Delirium associated with a combination of sertraline, haloperidol, and benztropine.
Topics: 1-Naphthylamine; Adult; Benztropine; Delirium; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Haloperidol; Humans; Lithium; Parkinson Disease, Secondary; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
[The extrapyramidal symptoms in the combination of lithium long-term lithium therapy with nortriptyline. A case report on the formation of a pathogenesis hypothesis].
Topics: Adult; Basal Ganglia Diseases; Bipolar Disorder; Chlorprothixene; Clopenthixol; Dibenzazepines; Drug Synergism; Drug Therapy, Combination; Female; Humans; Lithium; Long-Term Care; Nortriptyline; Parkinson Disease; Parkinson Disease, Secondary; Procyclidine; Propranolol; Synapses; Thioridazine | 1976 |
Involuntary movement disorders--each has a meaning all its own.
Topics: Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Butyrophenones; Chorea; Diagnosis, Differential; Humans; Lithium; Movement Disorders; Parkinson Disease, Secondary; Phenothiazines; Syndrome; Tremor | 1979 |
Acute lithium-induced parkinsonism precipitated by liquid protein diet.
Topics: Diet, Reducing; Dietary Proteins; Female; Humans; Lithium; Middle Aged; Parkinson Disease, Secondary; Protein Hydrolysates | 1978 |
[Abnormal movements induced by psychotropic drugs].
Topics: Chorea; Dyskinesia, Drug-Induced; Humans; Levodopa; Lithium; Movement Disorders; Parkinson Disease, Secondary; Psychotropic Drugs; Receptors, Dopamine; Receptors, Drug; Tremor | 1979 |
Cogwheel rigidity early in lithium treatment.
Topics: Basal Ganglia Diseases; Drug Interactions; Humans; Lithium; Parkinson Disease, Secondary; Time Factors; Tranquilizing Agents | 1977 |
Extrapyramidal side effects of lithium treatment.
Topics: Basal Ganglia Diseases; Female; Humans; Lithium; Male; Middle Aged; Parkinson Disease, Secondary | 1976 |
Updating psychotropic drug therapy.
Topics: Butyrophenones; Carbonates; Depression; Drug Combinations; Humans; Lithium; Medical History Taking; Parkinson Disease, Secondary; Psychotropic Drugs; Substance Withdrawal Syndrome | 1976 |
A possible interaction between lithium and diltiazem: case report.
Topics: Angina Pectoris; Benzazepines; Bipolar Disorder; Calcium; Diltiazem; Drug Synergism; Drug Therapy, Combination; Humans; Lithium; Male; Middle Aged; Parkinson Disease, Secondary | 1985 |
[Therapeutic and prophylactic use of lithium in periodic psychiatric diseases].
Topics: Cognition Disorders; Gastrointestinal Diseases; Humans; Lithium; Mental Disorders; Parkinson Disease, Secondary; Tremor | 1972 |
[Remarkable thymoanaleptic effect of lithium gluconate in recurrent melancholic states].
Topics: Antidepressive Agents; Depression; Gluconates; Humans; Lithium; Parkinson Disease, Secondary | 1971 |